Monteris Medical key facts
as of Oct 2026- Developer of magnetic resonance imaging-guided, laser-based systems designed for the ablation of brain lesions.
- Monteris Medical is valued at approximately $60.6M as of Oct 2026, set at its later-stage round, Jun 2017; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $275.0M across 1 recorded rounds; the latest was Seed Round ($3.7M) in Oct 2013.
- Notable investors include OSF Ventures, InnovaHealth Partners, Birchview Capital, CU Healthcare Innovation Fund, Madryn Asset Management.
- Monteris Medical has filed 1 Form D with the SEC, most recently Oct 2013 ($3.7M sold to 7 investors).
- Status: Privately Held (backing).
Valued at $60.6M at its later-stage round, Jun 2017. Nothing has traded since.
- ·Watch Monteris Medical: the Monday email on marks, rounds and moves
Monteris Medical funding rounds
1 roundsWho backs Monteris Medical
5Monteris Medical valuation
Monteris Medical was valued at $60.6 million at its later-stage round in Jun 2017. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Monteris Medical raised?
Monteris Medical has raised $275 million in total; 1 of its rounds is on record. The largest on record was a $3.7 million seed round in Oct 2013.
Monteris Medical has filed 1 Form D with the SEC, most recently in Oct 2013 ($3.7 million sold to 7 investors).
Monteris Medical investors
5 investors are on record for Monteris Medical, including OSF Ventures, InnovaHealth Partners, Birchview Capital and CU Healthcare Innovation Fund. The seed round in Oct 2013 drew 7 investors.
About Monteris Medical
Developer of magnetic resonance imaging-guided, laser-based systems designed for the ablation of brain lesions. The company's system applies focused laser energy to ablate brain tumors from the inside, with little or no effect on surrounding healthy tissue and provides clinicians with a neurosurgical tool that offers real-time control and visualization of the therapy during laser ablation treatment, enabling neurosurgeons to ablate brain lesions and brain tumors that may be difficult to approach via traditional methods.
- Sector
- Healthcare
- HQ
- Minnetonka, MN, United States
- Founded
- 1999
- Employees
- 120
- Website
- monteris.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.